Company · CIK 0001652130
Intellia Therapeutics, Inc.
NTLASearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$11.42+$0.08 (+0.705%)
NTLA · Last trade
- Prev close
- $11.34
- Range (29d)
- $11.34 – $13.07
On the record
Recent filings
- 144NTLAIntellia Therapeutics, Inc.0001950047-26-010054 · 5.4 KBSEC(opens sec.gov)
- 8-KNTLACurrent report0001193125-26-385194 · 258.0 KBSEC(opens sec.gov)
- 8-KNTLACurrent report0001193125-26-383645 · 236.2 KBSEC(opens sec.gov)
- 144NTLAIntellia Therapeutics, Inc.0001969223-26-000938 · 5.1 KBSEC(opens sec.gov)
- SCHEDULE 13GNTLAIntellia Therapeutics, Inc.0000093751-26-000484 · 8.1 KBSEC(opens sec.gov)
- 10-QNTLAQuarterly update0001193125-26-337952 · 9.9 MBSEC(opens sec.gov)
- 8-KNTLACurrent report0001193125-26-336772 · 407.1 KBSEC(opens sec.gov)
- 8-KNTLACurrent report0001193125-26-270358 · 291.4 KBSEC(opens sec.gov)
- 8-KNTLACurrent report0001193125-26-265934 · 212.6 KBSEC(opens sec.gov)
- 10-QNTLAQuarterly update0001193125-26-215740 · 9.0 MBSEC(opens sec.gov)
Insiders
- Atlas Venture Associates IX, LLC10% Owner
- Atlas Venture Associates IX, L.P.10% Owner
- Atlas Venture Fund IX, L.P.10% Owner
- Baker Bros. Advisors (GP) LLCFormer 10% owner
- BAKER BROS. ADVISORS LPFormer 10% owner
- BAKER FELIXFormer 10% owner
- BAKER JULIANFormer 10% owner
- BASTA JAMESEVP, General Counsel
- Bell GraemeEVP, Chief Financial Officer
- Bermingham NessanDirector, President & CEO
Tickers
Addresses
business
40 ERIE STREET SUITE 130
CAMBRIDGE, MA, 02139
mailing
40 ERIE STREET SUITE 130
CAMBRIDGE, MA, 02139
Same industry